Remove Documentation Remove Insurance Remove Specialty Pharmacies
article thumbnail

Piloting the PQA Specialty Pharmacy Turnaround Time Quality Measure

PQA

The use of specialty medicine has grown rapidly in recent decades, fueling parallel growth in the number of specialty pharmacies that serve patients who are prescribed specialty medications. Results of this work were published in the Journal of Managed Care & Specialty Pharmacy in October 2022.

article thumbnail

J&J copay lawsuit against drug benefit firm gets green light

pharmaphorum

While SaveOnSP is the nominal target of the lawsuit, it claims to expose one of the failings in the US health insurance sector, adding fire to an increasingly heated exchange between pharma manufacturers and pharmacy benefit managers (PBMs), which have blamed each other for high medicine prices in the US.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Does Blue Cross cover Humira?

The Checkup by Singlecare

However, its effectiveness and versatility come at a cost, which leaves many people looking to their insurance provider for help. Many health insurance and Medicare Part D plans will cover Humira, including some from Blue Cross Blue Shield, but it depends on the specific plan. Here’s what you need to know.

article thumbnail

Does Blue Cross Blue Shield cover Dupixent?

The Checkup by Singlecare

Specialty drugs like Dupixent are expensive to produce, and those costs are passed to consumers paying out of pocket. Insurance typically covers Dupixent, but coverage varies by plan and reason for taking. The Blue Cross and Blue Shield Association isn’t a single insurance provider.

article thumbnail

Does Blue Cross Blue Shield cover Remicade?

The Checkup by Singlecare

But its effectiveness and versatility come at a price that leaves many patients hoping for health insurance coverage. If your private insurance covers Remicade, there might be some caveats involved. Remicade (infliximab) is a tumor necrosis factor (TNF) blocker that’s approved to treat these conditions.